CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks
CAR T cell-based therapies have revolutionized the treatment of hematological malignancies such as leukemia and lymphoma within the last years. In contrast to the success in hematological cancers, the treatmen...
Source: Molecular Cancer - Category: Cancer & Oncology Authors: Lusine Hovhannisyan, Carsten Riether, Daniel M. Aebersold, Michaela Medov รก and Yitzhak Zimmer Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Hematology | Immunotherapy | Leukemia | Lymphoma | Radiation Therapy